Diabetes: Screening for T2DM does not reduce mortality


Previous modelling studies have indicated that implementation of a screening programme for type 2 diabetes mellitus (T2DM) could reduce mortality associated with this disease. However, results of an analysis of the first phase of the ADDITION-Cambridge trial suggest that screening does not lead to a reduction in either mortality associated with T2DM or all… (More)
DOI: 10.1038/nrendo.2012.200